CRVO · CervoMed Inc
United States · RS rating 9 · As of 2026-10-14
| Price | 2.29 USD |
|---|---|
| 1-day change | +0.9% |
| RS rating (overall / 1M / 3M / 12M) | 9 / 32 / 13 / 8 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 19 / 2 / 24 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +25.6% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +77.0% |
| Market cap (USD) | $35.6M |